Register entry
TALICIA HOLDINGS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 7
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
7| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10238606 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 11135172 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 11931463 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 9050263 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 9498445 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 9603806 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | product | Feb 2034 |
| 11878011 | TALICIAamoxicillin; omeprazole magnesium; rifabutin | use | May 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| TALICIAAMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN | GAIN Qualified infectious disease product (GAIN) | Nov 2027 |
Enquiry
Common questions
- Is TALICIA HOLDINGS INC FDA approved?
- TALICIA HOLDINGS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.